Description

Overview

The third annual Lennox-Lombroso Pediatric Epilepsy Conference continues Boston Children’s Hospital’s tradition of excellence in continuing medical education, specifically focusing on childhood epilepsy diagnosis, management, and research. This course will cover a wide range of topics, including medical advances, discoveries, and innovative technological approaches in areas such as epilepsy genetics, neurocritical care, computational neurophysiology, surgical procedures, and EEG development.

This Continuing Education (CE) course is designed to meet the educational needs of healthcare professionals who specialize in or have an interest in pediatric neurology, neurology, pediatric epilepsy, neuropsychology, epilepsy, clinical neurophysiology, and primary care.

In addition to presenting the latest advances and innovations in epilepsy research and care, the course will provide practitioners with clear guidance on how to apply this knowledge across all aspects of pediatric epilepsy. The core faculty comprises members from the Division of Epilepsy and Clinical Neurophysiology at Boston Children’s Hospital. Additionally, invited faculty members have been selected to honor and highlight alumni who continue to make significant contributions to the field.

Lennox Lombroso Symposium Guest Alumni Faculty:
2019	2023	2025
Gregory L. Holmes, M.D. Mohammad Mikati, M.D. James J. Riviello, M.D.	Blaise Bourgeois, M.D. Howard P. Goodkin, M.D., Ph.D. Cecil Hahn, M.D.	Mary Connolly, M.D. Elizabeth Donner, M.D. Michael Duchowny, M.D.

About the courses

This 2 day course is being offered in-person at the The Inn at Longwood Medical, 324 Longwood Ave, Boston MA 02115.

A virtual option is available for those who are unable to attend in-person.

Course Objectives:

Upon completion of this course, participants will:

1: Describe efforts to overcome benzodiazepine resistance in status epilepticus.
2: Recognize the effects of seizures and spikes on the developing brain.
3: Select the optimal timing and procedure for epilepsy surgery.
4: Choose the correct genetic test and translational/ treatment opportunity for the genetic epilepsies.

Registration

Course Cancellation, Transfer & Refund Policy

Online/Virtual Course Registrations: Due to the propriety materials and content of each course, online virtual courses orders are NOT eligible for refund, cancellation or transfer. Online training courses may NOT be transferred to another Participant. Participants have 2 weeks to access any virtual online course content. Participants have until the expiration date to access and complete any enduring material courses. Boston Children’s Hospital CE is not responsible for user technical difficulties including loss of internet, power outages, etc.

In-Person Course Registrations: For in person course registrations, refunds are available on the following schedule: 100% refund up to 8 weeks before the first day of the course; 50% refund up to 2 weeks before the first day of the course; No refunds will be processed for cancellations within 2 weeks of the first day of the course

Boston Children’s offers the opportunity to change your attendance preference: Should your circumstances change after you have registered for either the ONLINE or IN-PERSON program, you have the ability to change from one attendance option to the other up until two weeks before the program begins. Please contact us via email if you would like to make a change.

“No shows” for both in person and virtual courses are subject to the full course fee and no refunds will be issued once the course has started.

Refunds will be made in the following ways: For payments received by credit or debit cards, the same credit/debit card will be refunded.

*If you have extenuating circumstances, please contact us at continuingeducation@childrens.harvard.edu

Cancellation of Services
Although highly unlikely, in case an event is canceled or postponed, Boson Children’s can provide a full refund or offer a credit towards future events to those who have already registered.

Accreditation

In support of improving patient care, Boston Children’s Hospital is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

 

Physician
Boston Children’s Hospital designates this live activity for a maximum of  16.00 AMA PRA Category 1 Credits ™. Physicians should claim only credit commensurate with the extent of their participation in this activity.

Nurse
Boston Children’s Hospital designates this activity for 16.00 contact hours for nurses. Nurses should only claim credit commensurate with the extent of their participation in the activity.

Disclosure Policy 
Boston Children’s Hospital adheres to all ACCME Essential Areas, Standards, and Policies. It is Boston Children’s policy that those who have influenced the content of a CE activity (e.g. planners, faculty, authors, reviewers and others) disclose all relevant financial relationships with commercial entities so that Boston Children’s may identify and resolve any conflicts of interest prior to the activity. These disclosures will be provided in the activity materials along with disclosure of any commercial support received for the activity. Additionally, faculty members have been instructed to disclose any limitations of data and unlabeled or investigational uses of products during their presentations.

Disclosure Statement
The following planners, speakers, and content reviewers, on behalf of themselves, have reported the following relevant financial relationships with any entity producing, marketing, reselling, or distributing health care goods or services consumed by, or used on patients: 

Mitigation of Relevant Financial Relationships
Boston Children’s Hospital adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.